Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Ciprofloxacin (AN) TM

Active ingredients: ciprofloxacin

What it is used for

Ciprofloxacin is indicated for the treatment of infections caused by susceptible organisms in the conditions listed below: Urinary tract infections; Gonorrhoeal urethritis and cervicitis; Gastroenteritis; Bronchial Infections; Skin and skin structure infections; Bone and joint infections; Chronic bacterial prostatitis of mild to moderate severity. Inhalational anthrax (post-exposure): To reduce the incidence or progression of disease following exposure to aerosolized Bacillus anthracis. Ciprofloxacin serum concentrations achieved in humans serve as a surrogate endpoint reasonably likely to predict clinical benefit and provide the basis for this indication. Note: Typhoid and Paratyphoid infections and infections due to multi-resistant Staphylococcus aureus are excluded from the above due to insufficient data. Because Gram-positive organisms are generally less sensitive to ciprofloxacin, it may not be the drug of choice in cases with Gram-positive infections, such as pneumonia due to Streptococcus pneumoniae. Chronic bacterial prostatitis should be demonstrated by microbiological evidence localising infection to the prostate. Strains of Neisseria gonorrhoea resistant to ciprofloxacin have been reported in Australia. Appropriate culture and susceptibility tests should be performed before treatment in order to determine organism susceptibility to ciprofloxacin and after treatment as warranted by the clinical condition. Therapy with Ciprofloxacin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued. Ciprofloxacin is suitable to treat mixed infections caused by susceptible strains of both Gram-negative and Gram-positive aerobic bacteria. If anaerobic organisms are suspected as accompanying aetiologic agents, additional therapy should be considered.

How to take it

The way to take this medicine is: Oral. This medicine is taken by mouth.

  • Store below 25 degrees Celsius
  • Shelf lifetime is 3 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

White to off-white, capsule shaped, film coated tablets debossed with 'C' on one side and '93' on the other side

Images are the copyright of the Pharmacy Guild of Australia

Food interactions

For the active ingredient ciprofloxacin

  • Avoid excessive quantities of coffee or tea (Caffeine).
  • Avoid milk, calcium containing dairy products, iron, magnesium, zinc, antacids, or aluminum salts 2 hours before or 6 hours after using antacids while on this medication.
  • Take with a full glass of water.
  • Take without regard to meals.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on February 1, 2019. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient ciprofloxacin

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Download leaflet

For side effects, taking other medicines and more

Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website

Reporting side effects

You can help ensure medicines are safe by reporting the side effects you experience.

You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Back to top back to top

Need more information?

These trusted information partners have more on this topic.

Top results

Meningococcal disease

Meningococcal disease is caused by a bacterial infection and can lead to serious illness. It is uncommon in NSW, and occurs more often in winter and spring. Infants, small children, adolescents and young adults are most at risk. Early treatment is vital.

Read more on NSW Health website

Porphyria cutanea tarda - ACD

Porphyria cutanea tarda (PCT) is a rare condition which is characterised by blistering and fragility of the skin in sun exposed areas.

Read more on Australasian College of Dermatologists website

Legionnaire's disease (Legionella infection) information | myVMC

Legionnaires disease is a type of bacterial pneumonia or severe lung infection caused by Legionella bacteria. It can be treated with antibiotics.

Read more on myVMC – Virtual Medical Centre website

Anthrax (Bacillus anthracis infection) information | myVMC

Anthrax is infection with Bacillus anthracis, a bacteria found in soil. In humans it typically involves the skin (cutaneous anthrax), or the lungs.

Read more on myVMC – Virtual Medical Centre website

Common eye infections | Australian Prescriber

Antibiotic drops are not the treatment for all red eyes. An incorrect diagnosis can increase the risk of loss of vision.

Read more on Australian Prescriber website

Legionnaires' disease

Legionnaires' disease is a severe form of pneumonia. It is caused by Legionella bacteria which are found in damp or wet environments.

Read more on WA Health website

Anthrax - Better Health Channel

Anthrax is a rare but potentially fatal bacterial disease that occasionally infects humans.

Read more on Better Health Channel website

Extemporaneously compounded medicines | Issue 1 | Volume 40 | Australian Prescriber

Compounded medicines are not generally assessed for safety and efficacy. Read more about their regulation and short-term expiry dates.

Read more on Australian Prescriber website

Myasthenia gravis - myDr.com.au

Myasthenia gravis is a chronic muscle disease that produces weakness and abnormally rapid fatigue of the voluntary muscles.

Read more on myDr website

Healthdirect 24hr 7 days a week hotline

24 hour health advice you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information and advice

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo